A new role for extracellular Ca2+ in gap-junction remodeling: Studies in humans and rats

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 377, Issue 2, 2008, Pages 125-138

  Dhein, S ^a,d   Duerrschmidt, N ^a   Scholl, A ^a   Boldt, A ^a   Schulte, J S ^b   Pfannmuller B ^a   Rojas Gomez, D ^a   Scheffler, A ^a   Haefliger, J A ^c   Doll, N ^a   Mohr, F W ^a  

^a UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Atrial fibrillation; BMS605401; Ca2+ sensing receptor; Calcium; Connexin; Cyclosporine A; Gap junction; Verapamil

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BMS 605401; CALCIUM ION; CALCIUM SENSING RECEPTOR; CONNEXIN 40; CONNEXIN 43; CYCLOSPORIN A; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; UNCLASSIFIED DRUG; VERAPAMIL;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM SIGNALING; CELL MEMBRANE; CHANNEL GATING; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; GAP JUNCTION; GOLGI COMPLEX; HEART ATRIUM FIBRILLATION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ATRIAL FIBRILLATION; CALCIUM; CELLS, CULTURED; CONNEXIN 43; CONNEXINS; CYCLOSPORINE; FEMALE; GAP JUNCTIONS; HUMANS; MALE; MIDDLE AGED; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; VERAPAMIL;

EID: 41049095409     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-008-0265-z     Document Type: Article

References (51)

1. Allessie M, Ausma J, Schotten U (2002) Electrical, contractile and structural remodelling during atrial fibrillation. Cardiovasc Res 54:230-246
2. Arensbak B, Mikkelsen HB, Gustafsson F, Christensen T, Holstein-Rathlou NH (2001) Expression of connexin 34, 40 and 43 mRNA and protein in renal glomerular arterioles. Histochem Cell Biol 115:479-487
3. Arey BJ, Seethala R, Ma Z, Fura A, Morin J, Swartz JA, Vyas V, Yang W, Dickson JK, Feyen JHM (2005) A novel calcium-sensing receptor antagonist transiently stimulates parathyroid hormone secretion in vivo. Endocrinology 146:2015-2022
4. Boyden PA, Hoffman BF (1981) The effects on atrial electrophysiology and structure of surgically induced right atrial enlargement in dogs. Circ Res 49:1319-1331
5. Boyden PA, Tilley LP, Pham TD, Liu SK, Fenoglio JJ Jr, Wit AL (1982) Effects of left atrial enlargement on atrial transmembrane potentials and structure in dogs with mitral valve fibrosis. Am J Cardiol 49:1896-1908
6. Brundel BJJM, Van Gelder IC, Henning RH, Tielemann RG, Tuinenburg AE, Wietses M, Grandjean JG, Van Gilst WH, Crijns HJ (2001) Ion channel remodeling is related to intraoperative atrial refractory periods in patients with paroxysmal and persistent atrial fibrillation. Circulation 103:684-690
7. Brundel BJJM, Henning RH, Kampinga HH, Van Gelder IC, Crijns HJGM (2002) Molecular mechanisms of remodeling in human atrial fibrillation. Cardiovasc Res 54:315-324
8. Dhein S (2004) Pharmacology of gap junctions in the cardiovascular system. Cardiovasc Res 62:287-298
9. Dupont E, Ko Y-S, Rothery S, Coppen SR, Baghai M, Haw M, Severs NJ (2001) The gap junctional protein connexin40 is elevated in patients susceptible to postoperative atrial fibrillation. Circulation 103:842-849
10. Ebihara L (1995) Expression of dog connexin 40 and 45 in paired Xenopus oocytes. In: Kanno Y, Kataoka K, Shiba Y, Shibata Y, Shimazu T (eds) Intercellular communication through gap junctions. Progress in cell research vol. 4. Elesevier Science Publ., Amsterdam, pp 395-398
11. Elvan A, Huang X-D, Pressler ML, Zipes DP (1997) Radiofrequency catheter ablation of the atria eliminates pacing-induced sustained atrial fibrillation and reduces connexin 43 in dogs. Circulation 96:1675-1685
12. Falk MM (2000) Connexin-specific distribution within gap junctions revealed in living cells. J Cell Sci 113:4109-4120
13. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG (1995) Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 155:469-473
14. Firek L, Weingart R (1995) Modification of gap junction conductance by divalent cations and protons in neonatal rat heart cells. J Mol Cell Cardiol 27:1633-1643
15. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE (2001) Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention: the AnTi-coagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study. JAMA 285:2370-2375
16. Graham M (1997) The membranes of the secretory and exocytic pathways. In: Graham JM, Rickwood D (eds) Subcellular fractionation. A practical approach. Oxford University Press, Oxford, pp 205-242
17. qa-dependent ERK-independent pathway. J Biol Chem 276:13941-13948
18. Jongsma HJ, Wilders R (2000) Gap junctions in cardiovascular disease. Circ Res 86:1193-1197
19. Kostin S, Klein G, Szalay Z, Hein S, Bauer EP, Schaper J (2002) Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 54:361-379
20. Kwak BR, Van Veen TAB, Analbers LJS, Jongsma HJ (1995) TPA increases conductance but decreases permeability in neonatal rat cardiomyocyte gap junction channels. Exp Cell Res. 220:456-463
21. 2+ ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: an insight into the mechanism of atrial electrical remodelling. J Am Coll Cardiol 33:1231-1237
22. Laird DW, Castillo M, Ksprzak L (1995) Gap junction turnover, intracellular trafficking, and phosphorylation of connexin43 in Brefeldin-A-treated rat mammary tumor cells. J Cell Biol 131:1193-1230
23. Li DQ, Feng YB, Zhang HQ (2004) The relationship between gap junctional remodeling and atrial fibrillation in patients with rheumatic heart disease. Zhonghua Yi Xue Za Zhi 84:384-386
24. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with folin phenol reagent. J Biol Chem 193:265-275
25. Martin PEM, Blundell G, Ahman S, Errington RJ, Evans WH (2001) Multiple pathways in the trafficking and assembly of connexin26, 32 and 43 into gap junction intercellular communication channels. J Cell Sci 114:3845-3855
26. Moreno AP, Laing JG, Beyer EC, Spray DC (1995) Properties of gap junction channels formed of connexin 45 endogenously expressed in human hepatoma (SKHep1) cells. Am J Physiol 268:C356-C365
27. Müller A, Lauven M, Berkels R, Dhein S, Polder HR, Klaus W (1999) Switched single electrode voltage clamp amplifiers allow precise measurement of gap junction conductance. Am J Physiol 276:C980-C987
28. Musil L, Goodenough DA (1991) Biochemical analysis of connexin43 intracellular transport, phosphorylation and assembly into gap junction plaques. J Cell Biol 115:1357-1374
29. Musil L, Goodenough DA (1993) Multisubunit assembly of an integral plasma membrane channel protein, gap junction connexin43, occurs after exit from the ER. Cell 74:1065-1077
30. Nao T, Ohkusa T, Hisamatsu Y, Inoue N, Matsumoto T, Yamagata T, Kobayashi S, Yano M, Hamano K, Matsuzaki M (2003) Comparison of expression of connexin in right atrial myocardium in patients. Am J Cardiol 91:678-683
31. Polontchouk L, Haefliger J-A, Ebelt B, Schaefer T, Stuhlmann D, Mehlhorn U, Kuhn-Reignier F, DeVivie ER, Dhein S (2001) Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. J Am Coll Cardiol 38:883-891
32. Polontchouk L, Ebelt B, Jackels M, Dhein S (2002a) MAP kinases mediate the effects of endothelin-1 and angiotensin-II on the cardiac connexin expression. FASEB J 16:87-89
33. Polontchouk LO, Valiunas V, Haefliger JA, Eppenberger HM, Weingart R (2002b) Expression and regulation of connexins in cultured ventricular myocytes isolated from adult rat hearts. Pflüger's Arch 443:676-689
34. Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC (2003) Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev 83:1359-1400
35. Sakabe M, Fujiki A, Nishida K, Sugaro M, Nagasawa H, Tsuneda T, Mizumaki K, Inoue H (2004) Enalapril prevents perpetuation of atrial fibrillation by suppressing atrial fibrosis and over-expression of connexin43 in a canine model of atrial pacing-induced left ventricular dysfunction. J Cardiovasc Pharmacol 43:851-859
36. Salameh A, Dhein S (2005) Pharmacology of gap junctions. New pharmacological targets for treatment of arrhythmia, seizure and cancer? Biochim Biophys Acta 1719(1-2):36-58
37. Salameh A, Frenzel C, Boldt A, Rassler B, Glawe I, Schulte J, Mühlberg K, Zimmer H-G, Pfeiffer D, Dhein S (2006) Sub-chronic alpha- and beta-adrenergic regulation of cardiac gap junction protein expression. FASEB J 20(2):365-367
38. Spray DC, Harris AL, Bennett MVL (1981) Equilibrium properties of a voltage dependent junctional conductance. J Gen Physiol 77:77-93
39. Tfelt-Hansen J, Brown EM (2005) The calcium-sensing receptor in normal physiology and pathophysiology: a review. Crit Rev Clin Lab Sci 42:35-70
40. Tfelt-Hansen J, Hansen JL, Smaljilovic S, Terwilliger EF, Haunso S, Sheikh SP (2006) Calcium receptor is functionally expressed in neonatal ventricular cardiomyocytes. Am J Physiol 290:H1165-H1171
41. Tielemann RG, Crijns HJGM (2000) The "second factor" of tachycardia-induced atrial remodeling. Cardiovasc Res 46:364-366
42. Valiunas V, Gemel J, Brink PR, Beyer EC (2001) Gap junction channels formed by coexpressed connexin40 and connexin43. Am J Physiol 281:H1675-H1989
43. Van der Velden HMW, van Kempen MJA, Wijffels MCEF, van Zijverden M, Groenewegen WA, Allessie MA, Jongsma HJ (1998) Altered pattern of connexin40 distribution in persistent atrial fibrillation in the goat. J Cardiovasc Electrophysiol 9:596-607
44. Van der Velden HMW, Ausma J, Rook MB, Hellemous AJCGM, Van Veen TAAB, Allessie MA, Jongsma HJ (2000) Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat. Cardiovasc Res 46:476-486
45. 2+ currents and human atrial fibrillation. Circ Res 85:428-436
46. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D'Agostino RB, Murabito JM, Kannel WB, Benjamin EJ (2003a) Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham study. Circulation 107:2920-2925
47. Wang R, Xu C, Zhao W, Zhang J, Cao K, Yang B, Wu L (2003b) Calcium and polyamine regulated calcium-sensing receptors in cardiac tissue. Eur J Biochem 270:2680-2688
48. Weng S, Lauven M, Schaefer T, Polontchouk L, Grover R, Dhein S (2002) Pharmacological modification of gap junction coupling by an antiarrhythmic peptide via protein kinase C activation. FASEB J 16:1114-1116
49. Wetzel U, Boldt A, Lauschke J, Weigl J, Schirdewahn P, Dorszewski A, Doll N, Hindricks G, Dhein S, Kottkamp H (2005) Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiology. Heart 91:166-170
50. Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 22:983-988
51. Yan H, Chen JZ, Zhu JH, Ni YM, Yu GW, Hu SJ, Tao QM (2004) Expression of connexin in atrium of patients with atrial fibrillation and its signal transduction pathway. Zhonghua Yi Xue Za Zhi 84:209-213